CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Intas Pharmaceuticals Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Intas Pharmaceuticals Ltd
Corporate House
Near Sola Bridg, S. G. Highway, Thaltej
Phone: +91 7961577000p:+91 7961577000 AHMEDABAD, 380054  India Fax: +91 7926578862f:+91 7926578862
Business Summary
Intas Pharmaceuticals Ltd is an India-based vertically integrated global pharmaceutical formulation development, manufacturing, and marketing company. The Company focuses on the therapeutic segments including central nervous system (CNS), cardiovascular, diabetology, gastroenterology, urology and oncology. The Company offers a range of products in oncology and other hospital -based therapeutic segments in the Europe and United States. Its products include Allopurinol Tablets, Amitriptyline Hydrochloride Tablets, Anastrozole Tablets, Aripiprazole Tablets, Atorvastatin Tablets, Azacitidine Injection, Bivalirudin Injection, Buspirone Tablets and Busulfan Injection.
(Source: Company's Website)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/20103/31/2010Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Managing Director Nimish HasmukhBhai Chudgar 5/31/1985 5/31/1985
Managing Director Binish H.Chudgar 55 5/31/1985 5/31/1985
Managing Director Urmish H.Chudgar 59 9/30/1996 9/30/1996
8 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Accord Healthcare Ltd. Sage House North Harrow United Kingdom
ACCORD HEALTHCARE INC 1009 SLATER RD STE 210B DURHAM NC

Business Names
Business Name
Accord Healthcare Ltd.
Actavis Generics (Ireland)
Actavis Generics (UK)
Custodiol®
Essential Pharmaceuticals, LLC

General Information
Number of Employees: 5,211 (As of 9/30/2010)
Outstanding Shares: 103,476,698 (As of 9/30/2010)
Fax Number: +91 7926578862


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, August 30, 2023